InvestorsHub Logo

dstock07734

05/27/23 6:21 PM

#596539 RE: exwannabe #596536

Ex,

Simply put this way. If DCVax-L + Poly-ICLC + Keytruda + CSF1R-I works for several types of soild tumors, tumor-agnostic rule applies.

It is just this simple.

Dr Bala

05/27/23 9:29 PM

#596553 RE: exwannabe #596536

Total nonsense. Confusion in the post. Futile to argue against the best ever JAMA GBM data.

Dr Bala

05/27/23 9:48 PM

#596559 RE: exwannabe #596536

A totally misguided post. Misapprehension and misunderstanding in the post of even basic science related to GBM are evidenced by the nonsensical material in the post.

sentiment_stocks

05/28/23 2:32 AM

#596580 RE: exwannabe #596536

LL has indicated that DCVax-L works well with mesenchymal tumors. Could a mesenchymal designation be a type of biomarker?

biosectinvestor

05/28/23 6:15 AM

#596594 RE: exwannabe #596536

It targets any and all specific biomarker alterations. You appear to be confused by the flexibility of the platform. That is exactly what it targets, biomarker alterations from the patient’s normal cells, by their immune system governance system. It is the ultimate exact treatment that fits this definition.

georgebailey

05/28/23 9:21 AM

#596602 RE: exwannabe #596536

Severe misunderstanding entirely.

dennisdave

05/29/23 10:47 AM

#596752 RE: exwannabe #596536

Besides, the guidance, like others, specifically states that OS is compared to ECAs is not a valid endpoint.



The FDA has never said that, thats a blunt falsehood. Its not for nothing that you never quote FDA regulations with a link. Why is that?

dennisdave

05/29/23 10:56 AM

#596757 RE: exwannabe #596536

Confirmatory evidence could include, for example, adequate and well-controlled clinical
investigations in a related disease area, certain types of real world evidence20

Real-world data are data relating to patient health status and/or the delivery of health care routinely collected from a variety of sources. Examples of RWD include data derived from electronic health records, medical claims data, data from product or disease registries, and data gathered from other sources (such as digital health technologies) that can inform on health status.

Real-world evidence is the clinical evidence about the usage and potential benefits or risks of a medical product derived from analysis of RWD.


https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence